The psychological wellbeing outcomes of nonpharmacological interventions for older persons with insomnia symptoms: A systematic review and meta-analysis

Perach, Rotem; Allen, Calvin; Kapantai, Ioanna; Madrid‐Valero, Juan J.; Miles, Eleanor; Charlton, Rebecca A.; Gregory, Alice M.

doi:10.1016/j.smrv.2018.09.003

Cited by 12 publications

(12 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Non-pharmacological approaches have shown success among older adults and include: cognitivebehavioral therapies (CBT) for anxiety, insomnia, and/or pain; mindfulness; acupuncture; and physical therapy options. 14,18,19,[36][37][38] In the PCP environment, however, multisession interventions have lacked practicality because of time and resource limitations. In addition, many published interventions remain within research settings, involve small study samples, and consequently have not been widely implemented.…”

Section: Discussionmentioning

confidence: 99%

Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults

Wang

Slindee

Ruiz

et al. 2020

Population Health Management

View full text Add to dashboard Cite

The primary objective was to determine the prevalence and characteristics of older adults concurrently using opioids and other central nervous system (CNS)-active medications, and the specialties of providers who ordered the medications. A secondary objective was to document medication-related adverse effects associated with such concurrent drug use. Study populations were identified as older adults aged ‡65 years with 1 year continuous medical and drug plan enrollment during 2017 and opioid use of ‡2 prescriptions for ‡15 days' supply. CNSactive medications included benzodiazepines, non-benzodiazepine hypnotics, muscle relaxants, antipsychotics, and gabapentinoids. Provider specialties were identified from the National Provider Identification database. Characteristics associated with opioids only, opioids plus 1, and opioids plus ‡2 additional CNS-active medications were determined using multinomial logistic regression. Outcome measures during 2017 included injurious falls/fractures and ‡3 emergency room (ER) visits. Among eligible insureds (N = 209,947), 57% used opioids only, 28% used opioids plus 1 additional CNS medication, and 15% used ‡2 additional medications. About 60% of opioids and other concurrent CNS medications were prescribed by the same provider, generally a primary care provider. Benzodiazepines and gabapentinoids were most often used concurrently with opioids. Health status, insomnia, anxiety, depression, and low back pain had the strongest associations with concurrent medication use. Overall, concurrent use with ‡2 CNS medications increased the likelihood of injurious falls/fractures or ‡3 ER visits in this population by about 18% and 21%, respectively. Both patients and providers may benefit from an awareness of adverse outcomes associated with concurrent opioid and other CNS-active medication use.

show abstract

Section: Discussionmentioning

confidence: 99%

Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults

Wang

Slindee

Ruiz

et al. 2020

Population Health Management

View full text Add to dashboard Cite

show abstract

“…Intriguing were nonetheless the results of a small study that utilized experience sampling methods and revealed associations between a real-time objective air pollution index (derived from hourly real-time data released by the Beijing Environmental Protection Bureau) and in-time ratings of subjective wellbeing (negative association with affective ratings) and eudaimonic wellbeing (positive association with ratings of meaning and purpose in life) [34]. Both physical (in) activity and sleep covaried with ratings of psychological wellbeing and distress, and both behaviors were linked with risk of mental health disorders such as depression [35][36][37][38][39]. To what extent this "protection" is maintained when PA is performed in air polluted environments requires further study.…”

Section: Air Pollution and Mental Healthmentioning

confidence: 99%

Physical activity in an air-polluted environment: behavioral, psychological and neuroimaging protocol for a prospective cohort study (Healthy Aging in Industrial Environment study – Program 4)

et al. 2021

View full text Add to dashboard Cite

Background Air pollution has been linked to increased mortality and morbidity. The Program 4 of the Healthy Aging in Industrial Environment study investigates whether the health and wellbeing benefits of physical activity (PA) can be fully realized in individuals living in highly polluted environments. Herein, we introduce the behavioral, psychological and neuroimaging protocol of the study. Methods This is a prospective cohort study of N = 1500 individuals aged 18–65 years comparing: (1) individuals living in the highly polluted, industrial region surrounding the city of Ostrava (n = 750), and (2) controls from the comparison region with relative low pollution levels in Southern Bohemia (n = 750). Quota sampling is used to obtain samples balanced on age, gender, PA status (60% active runners vs. 40% insufficiently active). Participants are screened and complete baseline assessments through online questionnaires and in-person lab-based assessments of physiological, biomechanical, neuroimaging and cognitive function parameters. Prospective 12-month intensive monitoring of air pollution and behavioral parameters (PA, inactivity, and sleep) follows, with a focus on PA-related injuries and psychological factors through fitness trackers, smartphones, and mobile apps. Subsequently, there will be a 5-year follow-up of the study cohort. Discussion The design of the study will allow for (1) the assessment of both short-term variation and long-term change in behavioral parameters, (2) evaluation of the incidence of musculoskeletal injuries and psychological factors impacting behavior and injury recovery, and (3) the impact that air pollution status (and change) has on behavior, psychological resilience, and injury recovery. Furthermore, the integration of MRI techniques and cognitive assessment in combination with data on behavioral, biological and environmental variables will provide an opportunity to examine brain structure and cognitive function in relation to health behavior and air pollution, as well as other factors affecting resilience against and vulnerability to adverse changes in brain structure and cognitive aging. This study will help inform individuals about personal risk factors and decision-makers about the impact of environmental factors on negative health outcomes and potential underlying biological, behavioral and psychological mechanisms. Challenges and opportunities stemming from the timing of the study that coincided with the COVID-19 pandemic are also discussed.

show abstract

“…Many studies have proven that adolescents and their parents favor psychotherapy over pharmacotherapy [31], and cognitive behavioral therapy for insomnia (CBT-I) appears to be superior to hypnotics in the long run [32]. Metaanalysis has already supported that treating insomnia via CBT-I in both adults and elderly with depression has a positive effect on depressive symptoms [33,34]. To date, the literature has not been sys-tematically reviewed to evaluate the role of CBT-I in adolescents with comorbid insomnia and depressive symptoms.…”

Section: Insomnia and Depressive Symptoms: Shares The Common Charactementioning

confidence: 99%

Insomnia and Depressive Symptoms in Adolescents: Can Cognitive Behavioral Therapy for Insomnia Contribute to Improve Adolescents’ Depressive Symptoms?

Song

Fan

et al. 2019

Chronobiol Med

View full text Add to dashboard Cite

Psychological and pharmacological treatments for insomnia in adolescents have been associated with reduced insomnia symptoms and improved psychological wellbeing. Many studies have suggested or illustrated that adolescents and families strongly favor cognitive behavioral therapy (CBT) and other psychotherapies over pharmacotherapy. This narrative review aimed to examine whether CBT for insomnia (CBT-I) can improve depressive symptoms in adolescents who experience both insomnia and depressive symptoms. Four studies have been found to meet the inclusion criteria in this review. There is evidence to show that CBT-I can reduce depressive symptoms in adolescents with insomnia. This finding suggest that CBT-I is not only beneficial to sleep quality but also improve mental health. However, there is still unknown whether CBT-I may treat depression in adolescents with both disorders or whether CBT-I may prevent depression in those adolescents with insomnia who are at-risk of depression.

show abstract

The psychological wellbeing outcomes of nonpharmacological interventions for older persons with insomnia symptoms: A systematic review and meta-analysis

Abstract: M (2019) The psychological wellbeing outcomes of nonpharmacological interventions for older persons with insomnia symptoms: a systematic review and meta-analysis. Sleep Medicine Reviews, 43. pp. 1-13.

Cited by 12 publications

References 67 publications

Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults

Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults

Physical activity in an air-polluted environment: behavioral, psychological and neuroimaging protocol for a prospective cohort study (Healthy Aging in Industrial Environment study – Program 4)

Insomnia and Depressive Symptoms in Adolescents: Can Cognitive Behavioral Therapy for Insomnia Contribute to Improve Adolescents’ Depressive Symptoms?

Contact Info

Product

Resources

About